Sunday, January 18, 2026

Prevalence and Predictors of Major Depression in HIV-Infected Patients on Antiretroviral Therapy in Bamenda, a Semi-Urban Center in Cameroon

Authors: Bradley N. Gaynes, Brian W. Pence, Julius Atashili, Julie O’Donnell, Dmitry Kats, Peter M. Ndumbe

DOI: 10.1371/journal.pone.0041699

Abstract Summary

Depression affects 1 in 5 HIV patients on antiretroviral therapy in Cameroon, with prevalence matching other conditions like tuberculosis already integrated into WHO care guidelines. Yet only 33% discussed depression with healthcare providers, and just 12% received effective treatment. Researchers advocate for incorporating mental health screening and treatment into standard HIV care protocols.

Why Brain? 🧠

Study reveals 1 in 5 HIV patients in Cameroon have major depression, yet only 12% receive treatment, highlighting urgent need to integrate mental health care into routine HIV services in resource-limited settings.

License: CC BY.


The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.

share this recipe:
Facebook
X
Email
Print

Still hungry? Here’s more